Press Releases

Filter by Category

Filter by Program

Filter by Publish Date

Rare Disease Cures Accelerator-Data and Analytics Platform First Year Milestones Highlighted at Virtual Workshop

C-Path, NORD, FDA and more come together to showcase the importance of data sharing in rare disease drug development

September is National Sickle Cell Awareness Month TUCSON, Ariz., Sept. 17, 2020 — The Critical Path Institute (C-Path) today

Safety biomarkers aim to provide an additional tool for detecting acute drug-induced skeletal muscle injury in phase 1 clinical tr

Biomarker aims to provide an additional tool for detecting the onset of hepatic injury in clinical trials involving patients with

TUCSON, Ariz., July 14, 2020 — Tucson-based Critical Path Institute (C-Path) today proudly announced that the analytics team f

Clinicians to report novel uses of existing drugs through FDA-NCATS CURE ID Mobile App. TUCSON, Ariz., June 23, 2020 — As millio

June 20, 2020

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan

TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas

TUCSON, Ariz., April 30, 2020 — Tucson-based Critical Path Institute (C-Path) today announced the appointment of two new

Recommendations provided for sponsors and eCOA providers to facilitate the continued collection of PRO data in clinical trials. &n